The U.S. industry has immersive productive footprints, with an emphasis on raising softgel capabilities and innovative formulation development, spurring the overall market progression.
Market Overview
The U.S. vitamins, minerals, and supplements CDMO market covers robust third-party firms that facilitate outsourced, end-to-end services, like formulation development, manufacturing, & packaging of dietary products. In the U.S., this market has a pivotal role in bolstering immunity, wellness, and mental health among millennials & Gen Z, which surges product innovation & expedited time-to-market needs. Numerous CDMOs are shifting towards novelty in gummy production capacity, probiotic formulations, & high-bioavailability capsules.
Global Market Growth
The global vitamins, minerals, and supplements CDMO market size was estimated at USD 48.18 billion in 2025 and is predicted to increase from USD 52.84 billion in 2026 to approximately USD 121.38 billion by 2035, expanding at a CAGR of 9.68% from 2026 to 2035.
Market Forecasts
Gradually, the U.S. vitamins, minerals, and supplements CDMO market will emphasize procuring organic raw materials & offer transparent, traceable, clean-label manufacturing. Additionally, the U.S. CDMOs will have a major chance in the breakthroughs of nanoencapsulation & liposomal delivery systems to boost nutrient absorption rates. To raise market entry, CDMOs will reinforce various services, like R&D, product formulation, testing, packaging, & regulatory compliance.
Market Segmentation Overview
- By service type, the manufacturing services segment held a major share of 42% of the market in 2025. Dominance is mainly fueled by CDMO’s cost-effectiveness, scalability, and emerging large-scale outsourcing, which lowers capital investment for brands. The U.S. vitamins, minerals, and supplements CDMO market is increasingly fostering custom formulation, blending, & turnkey manufacturing. Also, increasing demand for CDMO expertise in sustained-release capsules & nanoencapsulation fuels the segmental growth.
- By dosage form, the tablets segment led with a 34% share of the market in 2025. Tablets offer longer shelf life, greater affordability in production, and easy scaling up, which raises the overall adoption. Many U.S. CDMOs are focusing on the development of sustained-release, rapid-dissolve, & chewable tablets that enhance bioavailability & consumer adherence.
- By product type, the dietary supplements segment captured a dominant share of 40% of the U.S. vitamins, minerals, and supplements CDMO market in 2025, driven by intense consumer demand for preventive immunity support, high-dose vitamins, and personalized nutrition. Rising health awareness post-pandemic, coupled with a booming senior population, spurred massive outsourcing of complex, specialized manufacturing to reliable, compliant CDMO partners.
- By end user, the nutraceutical companies segment registered dominance with 36% share in 2025. Prominent drivers are a rise in demand for tailored nutrition, clean-label products, and collagen, probiotics/prebiotics, magnesium, vitamin D, & functional ingredients, including ashwagandha. Ongoing AI-powered formulation customization, precision nutrition subscriptions, & wearable technology integration support the overall development of these firms.
Top Companies in the U.S. Vitamins, Minerals, and Supplements CDMO Market
The respective market has Catalent, Inc., Lonza Group AG, Aenova Group, & NutraScience Labs as leading players that specialise in advanced softgel capabilities and huge production footprints. From these, Catalent, Inc. was dominant, which has explored its Softgel formulation technologies & lipid-based delivery systems to crucially enhance the absorption of lipophilic nutrients & vitamins.
Segments Covered in the Report
By Service Type
- Product development
- Formulation Development
- Analytical & Stability Testing
- Process Development & Scale-up
- Manufacturing Services
- API/Nutrient Synthesis
- Finished Dosage Manufacturing
- Packaging & Labelling
- Packaging Services
- Primary Packaging
- Secondary Packaging
- Regulatory & Compliance Services
- Regulatory Filing Support
- Quality Assurance & Audits
- Supply Chain & Logistics
- Warehousing
- Distribution Management
By Dosage Form
- Tablets
- Immediate Release Tablets
- Chewable Tablets
- Effervescent Tablets
- Capsules
- Hard Gelatin Capsules
- Softgel Capsules
- Powders
- Liquids
- Gummies & Chewables
By Product Type
- Vitamins
- Vitamin A, B, C, D, E, K
- Multivitamins
- Minerals
- Calcium
- Magnesium
- Iron
- Zinc
- Dietary Supplements
- Herbal Supplements
- Protein & Amino Acids
- Omega Fatty Acids
- Probiotics & Prebiotics
By End User
- Nutraceutical Companies
- Pharmaceutical Companies
- Direct-to-Consumer (DTC) Brands
- Retail & Private Label Brands